These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28025157)

  • 1. Reply.
    Wang C; Chen G; Lau G
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):605-606. PubMed ID: 28025157
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infection.
    Thibault V
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):145-147. PubMed ID: 29371018
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct-acting antiviral therapy for hepatitis E virus?
    Kamar N; Wang W; Dalton HR; Pan Q
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):154-155. PubMed ID: 28404127
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B Reactivation With Hepatitis C Treatment: Bringing Some Clarity to the Black Box.
    Ma AT; Feld JJ
    Gastroenterology; 2018 Mar; 154(4):795-798. PubMed ID: 29425929
    [No Abstract]   [Full Text] [Related]  

  • 5. Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals.
    Ozaras R; Mete B; Tabak F
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):605. PubMed ID: 27923721
    [No Abstract]   [Full Text] [Related]  

  • 6. Virology of hepatitis B and C viruses and antiviral targets.
    Pawlotsky JM
    J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBV recurrence after HCV clearance on DAAs: Sometimes they come back.
    Calvaruso V; Craxì A
    J Hepatol; 2017 Nov; 67(5):898-901. PubMed ID: 28864279
    [No Abstract]   [Full Text] [Related]  

  • 8. [The Past and Future of Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Infection].
    Hayashi J
    Rinsho Byori; 2015 Jun; 63(6):746-7. PubMed ID: 26548239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.
    Buti M
    IDrugs; 2008 Apr; 11(4):239-41. PubMed ID: 18379952
    [No Abstract]   [Full Text] [Related]  

  • 10. Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge.
    Sterling RK
    Am J Gastroenterol; 2003 Oct; 98(10):2130-4. PubMed ID: 14572556
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-resistant viral hepatitis.
    Wright M; Main J; Thomas HC
    J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
    Ohashi H; Koizumi Y; Fukano K; Wakita T; Perelson AS; Iwami S; Watashi K
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4527-E4529. PubMed ID: 28512226
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B and C Viruses and Biologics.
    Grewal P; Sanghera R
    Skin Therapy Lett; 2017 Jul; 22(4):7-9. PubMed ID: 28732153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: hepatitis C direct acting antiviral agents and the kidney-authors' reply.
    Maan R; Feld JJ; Duarte-Rojo A
    Aliment Pharmacol Ther; 2017 Aug; 46(3):379-380. PubMed ID: 28677289
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-based and animal models for hepatitis B and C viruses.
    Schinazi RF; Ilan E; Black PL; Yao X; Dagan S
    Antivir Chem Chemother; 1999 May; 10(3):99-114. PubMed ID: 10431609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance in antiviral treatment for infections with hepatitis B and C viruses.
    Yotsuyanagi H; Koike K
    J Gastroenterol; 2007 May; 42(5):329-35. PubMed ID: 17530355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to: "Real-world data on antiviral treatments for hepatitis C virus infections: Can we define intention to treat or per protocol analyses?".
    Buggisch P; Zeuzem S
    J Hepatol; 2018 Aug; 69(2):553. PubMed ID: 29758332
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral Research--16th International Congress: HBV and HCV. 27 April-1 May 2003, Savannah, GA, USA.
    Smee D
    IDrugs; 2003 Jun; 6(6):518-21. PubMed ID: 12861975
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to the comment "infection with hepatitis C virus, interferon α and lupus: an odd association".
    Auñón P; Morales E
    Nefrologia; 2015; 35(5):507-8. PubMed ID: 26306965
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
    Kohli A
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.